Autopsy report · NCT03332030

Stem Cells in NF1 Patients With Tumors of the Central Nervous System

“Suspended due to cessation of funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Roger Packer

Sponsor type

University, hospital or other

Conditions

Neurofibromatosis Type 1; Tumors of the Central Nervous System

Interventions

Collection of Stem Cells

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
  “Suspended due to lack of funding.” (85% match in meaning)
• MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
  “Funding suspended prior to completing enrollment of all participants.” (76% match in meaning)
• Supplementation With Omega-3: Mechanism of Action
  “This study was suspended because there is no more funds to complete the study.” (70% match in meaning)
• Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
  “Study suspended due to low accrual” (69% match in meaning)
• Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
  “Terminated due to loss of funding” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.